Abstract
Few studies have investigated the prevalence of 22q11.2 deletion syndrome (22q11.2DS) among patients with isolated heart defects or nonconotruncal heart defects. Polymerase chain reaction (PCR) followed by length polymorphism restriction fragment analysis (RFLP) is useful for low-cost molecular diagnosis and screening. This cross-sectional study included 392 patients with congenital heart disease, described clinical features, and performed PCR–RFLP for analysis of polymorphism in three loci with a high heterozygosity rate located in the typically deleted region of 1.5 megabases. Heterozygosity excluded 22q11.2DS. Patients with homozygosity for the three markers underwent multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH) for the final diagnosis, estimating the prevalence of 22q11.2DS. The use of PCR–RFLP excluded 22q11.2DS in 81.6 % (n = 320) of 392 patients. Of the remaining 72 patients, 65 underwent MLPA, showing 22q11.2DS in five cases (prevalence, 1.27 %). Four of these five patients underwent FISH, confirming the MLPA results. All five patients with the deletion had heart diseases commonly found with 22q11.2DS (interrupted aortic arch, persistent truncus arteriosus, tetralogy of Fallot, and ventricular septal defect plus atrial septal defect). Two patients had congenital extracardiac anomaly (one with arched palate and micrognathia and one with hypertelorism). Three patients reported recurrent respiratory infections, and one patient reported hypocalcemia. All were underweight or short in stature for their age. This study contributed to showing the prevalence of 22q11.2DS in patients with any congenital heart disease, with or without other features of the syndrome. Patients with 22q11.2DS may not have all the major features of the syndrome, and those that are found may be due to the heart defect.
Similar content being viewed by others
References
Amati F, Conti E, Novelli A et al (1999) Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome. Eur J Hum Genet 7:903–909
Botto LD, May K, Fernhoff PM et al (2003) A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112:101–107
Brauner R, Le Harivel de Gonneville A, Kindermans C et al (2003) Parathyroid function and growth in 22q11.2 deletion syndrome. J Pediatr 142:504–508
Chegar BE, Tatum SA, Marrinan E, Shprintzen RJ (2006) Upper airway asymmetry in velo-cardio-facial syndrome. Int J Pediatr Otorhinolaryngol 70:1375–1381
Chen YF, Kou PL, Tsai SJ et al (2006) Computational analysis and refinement of sequence structure on chromosome 22q11.2 region: application to the development of quantitative real-time PCR assay for clinical diagnosis. Genomics 87:290–297
Debbané M, Glaser B, David MK, Feinstein C, Eliez S (2006) Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 84:187–193
Driscoll DA (1994) Genetic basis of DiGeorge and velocardiofacial syndromes. Curr Opin Pediatr 6:702–706
Driscoll DA, Emanuel BS, Mitchell LE, Budarf ML (1997) PCR assay for screening patients at risk for 22q11.2 deletion. Genet Test 1:109–113
Eirís-Puñal J, Iglesias-Meleiro JM, Blanco-Barca MO et al (2003) Phenotypic variability of deletion 22q11.2: an analysis of 16 observations with special emphasis on the neurological manifestations. Rev Neurol 37:601–607 (in Spanish)
Fernández L, Lapunzina P, Arjona D et al (2005) Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome. Clin Genet 68:373–378
Funke BH, Brown AC, Ramoni MF et al (2007) A novel, single-nucleotide polymorphism-based assay to detect 22q11 deletions. Genet Test 11:91–100
Gawde H, Patel ZM, Khatkhatey MI et al (2006) Chromosome 22 microdeletion by FISH in isolated congenital heart disease. Indian J Pediatr 73:885–888
Gerdes M, Solot C, Wang PP et al (1999) Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet 85:127–133
Gioli-Pereira L, Pereira AC, Mesquita SM, Lopes AA, Krieger JE (2006) PCR screening for 22q11.2 microdeletion: development of a new cost-effective diagnostic tool. Clin Chim Acta 369:78–81
Gitai DL, Romcy-Pereira RN, Gitai LL, Leite JP, Garcia-Cairasco N, Paco-Larson ML (2008) Genes and epilepsy I: epilepsy and genetic alterations. Rev Assoc Med Bras 54:272–278 (in Portuguese)
Goodship J, Cross I, LiLing J, Wren C (1998) A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 79:348–351
Greenhalgh KL, Aligianis IA, Bromilow G et al (2003) 22q11 Deletion: a multisystem disorder requiring multidisciplinary input. Arch Dis Child 88:523–524
Halder A, Jain M, Kabra M, Gupta N (2008) Mosaic 22q11.2 microdeletion syndrome: diagnosis and clinical manifestations of two cases. Mol Cytogenet 1:18
Kariyazono H, Ohno T, Ihara K et al (2001) Rapid detection of the 22q11.2 deletion with quantitative real-time PCR. Mol Cell Probes 15:71–73
Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11:1–190
Lahiri DK, Nurnberger JI Jr (1991) A rapid nonenzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444
Maharasingam M, Ostman-Smith I, Pike MG (2003) A cohort study of neurodevelopmental outcome in children with DiGeorge syndrome following cardiac surgery. Arch Dis Child 88:61–64
McDonald-McGinn DM, Kirschner R, Goldmuntz E et al (1999) The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 10:11–24
Moreno Izco F, Zuazo Zamalloa E, González Alvaredo S, Bereciartu Irastorza P (2009) 22q11 Deletion syndrome: an expanding phenotype. Neurologia 24:69–71 (in Spanish)
Payne RM, Johnson MC, Grant JW, Strauss AW (1995) Toward a molecular understanding of congenital heart disease. Circulation 91:494–504
Pereira AC, Corrêa RF, Mota GF, Kim CA, Mesquita SF, Krieger JE (2003) High-specificity PCR screening for 22q11.2 microdeletion in three different ethnic groups. Braz J Med Biol Res 36:1359–1365
Rauch A, Zink S, Zweier C et al (2005) Systematic assessment of atypical deletions reveals genotype–phenotype correlation in 22q11.2. J Med Genet 42:871–876
Rosa RF, Pilla CB, Pereira VL et al (2008) 22q11.2 Deletion syndrome in patients admitted to a cardiac pediatric intensive care unit in Brazil. Am J Med Genet A 146A:1655–1661
Ryan AK, Goodship JA, Wilson DI et al (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34:798–804
Scambler PJ (2000) The 22q11 deletion syndromes. Hum Mol Genet 9:2421–2426
Schaan BD, Huber J, Leite JC, Kiss A (2006) Cardiac surgery unmasks latent hypoparathyroidism in a child with the 22q11.2 deletion syndrome. J Pediatr Endocrinol Metab 19:943–946
Shaikh TH, O’Connor RJ, Pierpont ME et al (2007) Low copy repeats mediate distal chromosome 22q11.2 deletions: sequence analysis predicts breakpoint mechanisms. Genome Res 17:482–491
Stachon AC, Baskin B, Smith AC et al (2007) Molecular diagnosis of 22q11.2 deletion and duplication by multiplex ligation dependent probe amplification. Am J Med Genet A 143A:2924–2930
Van Aken K, De Smedt B, Van Roie A et al (2007) Motor development in school-aged children with 22q11 deletion (velocardiofacial/DiGeorge syndrome). Dev Med Child Neurol 49:210–213
Vervoordeldonk SF, Doumaid K, Remmerswaal EB et al (1998) Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion. Br J Haematol 102:1004–1009
Vorstman JA, Jalali GR, Rappaport EF, Hacker AM, Scott C, Emanuel BS (2006) MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum Mutat 27:814–821
Widdershoven JC, Beemer FA, Kon M, Dejonckere PH, Mink van der Molen AB (2008) Possible mechanisms and gene involvement in speech problems in the 22q11.2 deletion syndrome. J Plast Reconstr Aesthet Surg 61:1016–1023
Wozniak A, Wolnik-Brzozowska D, Wisniewska M et al (2010) Frequency of 22q11.2 microdeletion in children with congenital heart defects in western Poland. BMC Pediatr 10:88
Acknowledgments
The acknowledge the contributions of Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS), Centro Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundo de Apoio à Pesquisa do Instituto de Cardiologia/Fundação Universitária de Cardiologia à Ciência e à Cultura (FAPICC), Fundo de Incentivo à Pesquisa e Eventos/Hospital de Clínicas de Porto Alegre (FIPE-HCPA), and RedeBRIM Project/Centro Nacional de Desenvolvimento Científico e Tecnológico (CNPq)/Brazil.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huber, J., Peres, V.C., de Castro, A.L. et al. Molecular Screening for 22Q11.2 Deletion Syndrome in Patients With Congenital Heart Disease. Pediatr Cardiol 35, 1356–1362 (2014). https://doi.org/10.1007/s00246-014-0936-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-014-0936-0